glp 1 for mcas and tirzepatide Understanding Mast Cell Activation Syndrome (MCAS) Symptoms GLP-1 Genetics: How Genes Affect – Could GLP-1 Medications Be a

Gender gaps show up in both outcomes and access

D.SantM

The absolute risk increase for diabetic retinopathy complications was greater among patients with a history of diabetic retinopathy at baseline (semaglutide 8.2%, placebo 5.2%) than among patients without a known history of diabetic retinopathy (semaglutide 0.7%, placebo 0.4%)

Just a few years ago, it was a well-kept secret among celebrities, but the secret is really out: one in eight adults in the U.S

Intriguingly however, very recent data on anti-CD20 B cell depleting agents might be showing some efficacy in progressive MS, although the effect of peripheral B cell depletion on PIRA cannot be interpreted as independent of its effect on silencing acute/adaptive inflammatory activity (Kappos et al., 2020)